PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
27-Aug-2020 PureTech Health plc - Half-Year Report PureTech
27-Aug-2020 Immunocore announces publication of preclinical data in Hepatology showing the potential of ImmTAV® bispecific molecules for functional cure of chronic hepatitis B Immunocore
27-Aug-2020 Tiziana Life Sciences CEO Updates Shareholders on its Patent Portfolio, Clinical Pipeline, and Strategy in an Exclusive Interview Tiziana Life Sciences plc
27-Aug-2020 Nordic Nanovector ASA: Results for the Second Quarter and First Half 2020 Nordic Nanovector
27-Aug-2020 BIOCARTIS ANNOUNCES 2020 HALF-YEAR RESULTS ON 3 SEPTEMBER 2020 Biocartis
27-Aug-2020 Digital International Liver Congress 2020: A lifeline for liver transplant patients on waiting list as new model reduces mortality in Europe EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER (EASL)
27-Aug-2020 Vaccitech receives government grant for COVID-19 vaccine research Vaccitech
27-Aug-2020 SQI Diagnostics Inc. Announces Stock Option Grant SQI Diagnostics Inc.
27-Aug-2020 Global Brain Tumor Therapeutics Market Targeted to Reach $3.4 Billion by 2025 Financialnewsmedia.com
27-Aug-2020 Global Brain Tumor Therapeutics Market Targeted to Reach $3.4 Billion by 2025 Financialnewsmedia.com
27-Aug-2020 Pharmaceutical Companies PharmiWeb
27-Aug-2020 Pharma Jobs in Australia PharmiWeb
27-Aug-2020 BioInvent Interim Report January 1 - June 30, 2020 BioInvent
26-Aug-2020 Abcentra Appoints Accomplished Drug Developer, Timothy Wright, to Board of Directors Abcentra
26-Aug-2020 Chi-Med Highlights Clinical Data to be Presented at the Upcoming ESMO Virtual Congress 2020 Chi-Med
26-Aug-2020 Verona Pharma to Present Phase 2b data with Ensifentrine in COPD at the European Respiratory Society International Congress 2020 Verona Pharma plc
26-Aug-2020 GC Aesthetics announces the release of minimal-touch insertion device, HydroCone GC Aesthetics
26-Aug-2020 XBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization XBiotech Inc
26-Aug-2020 MC2 Therapeutics Announces Collaboration Agreement with EPI Health on Commercialization of Newly Approved Psoriasis Drug, WYNZORA® Cream, in the US MC2 Therapeutics
26-Aug-2020 New Nasal Gel Evaluated for its Protective Action Against Human Rhinovirus 16 (HRV-A16) Infection in Nasal Epithelial Cells MetP® Pharma AG